Business Services Industry

Elan Corporation, PLC - Tysabri US Reintroduction FDA Approval Call - Research and Markets offers a transcript of 'Elan Corporation, PLC' Conference Call

Business Wire, June 6, 2006

DUBLIN, Ireland -- The Elan Corporation, PLC (NYSE:ELN) Corporate Conference Call took place on 6-Jun-06 8:30am ET.

The Co. reported on 06/06/06 that the FDA has decided to allow TYSABRI back in the market and make it available to patients. BIIB believes that the reintroduction of TYSABRI offers new hope as an important therapeutic choice for patients living with a disabling and devastating disease.

More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/90285.> This document provides verbatim text of the conference call.

COPYRIGHT 2006 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale